Tirzepatide — dual GIP/GLP-1 receptor agonist research compound
Tirzepatide is a synthetic 39-amino-acid peptide that acts on two incretin receptors at once: the GIP receptor and the GLP-1 receptor. That dual action sets tirzepatide apart from classic GLP-1 analogues and makes it a heavily studied molecule in research into glucose handling, insulin secretion and energy balance.
Product information
- ✅ High purity — pharmaceutical-grade quality
- ✅ Available in 10MG per vial
- ✅ Lyophilised (freeze-dried) for maximum stability
- ✅ In stock — shipped the same day on orders before 17:00
- ✅ Discreetly packaged
Scientific background
Tirzepatide is built around a GIP-like amino-acid chain with a C20 fatty-acid chain attached to the molecule. That acylation drives binding to albumin, so the peptide breaks down considerably more slowly and has a long duration of action. In the scientific literature tirzepatide is studied mainly in research into incretin signalling, insulin and glucagon response, gastric emptying and metabolic processes.
Why 10MG?
- 10MG — a generous vial size, enough for a full research protocol
- Measured out accurately after reconstitution, with minimal residual loss per vial
Storage
Store unreconstituted at 2–8°C, dark and dry. After reconstitution with bacteriostatic water, store at 4°C and use within two to four weeks. Avoid repeated freezing and thawing.
Reviews
There are no reviews yet.